These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38572829)

  • 1. How renal toxins respond to renal function deterioration and oral toxic adsorbent in pH-controlled releasing capsule.
    Liu WS; Liang SS; Cheng MM; Wu MT; Li SY; Cheng TT; Liu TY; Tsai CY; Lai YT; Lin CH; Wang HT; Tsou HH
    Environ Toxicol; 2024 Jul; 39(7):3930-3943. PubMed ID: 38572829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
    Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CharXgen-Activated Bamboo Charcoal Encapsulated in Sodium Alginate Microsphere as the Absorbent of Uremic Toxins to Retard Kidney Function Deterioration.
    Lin CJ; Sun CY; Wu CJ; Wu CC; Wu V; Lin FH
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
    Liu WC; Tomino Y; Lu KC
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum total p-cresol and indoxyl sulfate correlated with stage of chronic kidney disease in renal transplant recipients.
    Huang ST; Shu KH; Cheng CH; Wu MJ; Yu TM; Chuang YW; Chen CH
    Transplant Proc; 2012 Apr; 44(3):621-4. PubMed ID: 22483453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzobiotics-A Novel Therapy for the Elimination of Uremic Toxins in Patients with CKD (EETOX Study): A Multicenter Double-Blind Randomized Controlled Trial.
    Saxena A; Srinivasa S; Veerappan I; Jacob C; Mahaldar A; Gupta A; Rajagopal A
    Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease.
    Rossi M; Campbell KL; Johnson DW; Stanton T; Vesey DA; Coombes JS; Weston KS; Hawley CM; McWhinney BC; Ungerer JP; Isbel N
    Arch Med Res; 2014 May; 45(4):309-17. PubMed ID: 24751327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New oral spherical carbon adsorbent effectively reduces serum indoxyl sulfate levels in moderate to advanced chronic kidney disease patients: a multicenter, prospective, open-label study.
    Kim SH; Jhee JH; Choi HY; Lee SH; Shin SK; Lee SY; Yang DH; Yi JH; Han SW; Jo YI; Park HC
    BMC Nephrol; 2020 Jul; 21(1):317. PubMed ID: 32736531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired Tubular Secretion of Organic Solutes in Advanced Chronic Kidney Disease.
    Mair RD; Lee S; Plummer NS; Sirich TL; Meyer TW
    J Am Soc Nephrol; 2021 Nov; 32(11):2877-2884. PubMed ID: 34408065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Kidney Clearance of Secretory Solutes and Cardiovascular Events: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Chen Y; Zelnick LR; Huber MP; Wang K; Bansal N; Hoofnagle AN; Paranji RK; Heckbert SR; Weiss NS; Go AS; Hsu CY; Feldman HI; Waikar SS; Mehta RC; Srivastava A; Seliger SL; Lash JP; Porter AC; Raj DS; Kestenbaum BR;
    Am J Kidney Dis; 2021 Aug; 78(2):226-235.e1. PubMed ID: 33421453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial.
    Ramos CI; Armani RG; Canziani MEF; Dalboni MA; Dolenga CJR; Nakao LS; Campbell KL; Cuppari L
    Nephrol Dial Transplant; 2019 Nov; 34(11):1876-1884. PubMed ID: 29939302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indoxyl sulfate, not p-cresyl sulfate, is associated with cognitive impairment in early-stage chronic kidney disease.
    Yeh YC; Huang MF; Liang SS; Hwang SJ; Tsai JC; Liu TL; Wu PH; Yang YH; Kuo KC; Kuo MC; Chen CS
    Neurotoxicology; 2016 Mar; 53():148-152. PubMed ID: 26797588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.
    Rossi M; Johnson DW; Morrison M; Pascoe EM; Coombes JS; Forbes JM; Szeto CC; McWhinney BC; Ungerer JP; Campbell KL
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):223-31. PubMed ID: 26772193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD.
    Poesen R; Viaene L; Verbeke K; Claes K; Bammens B; Sprangers B; Naesens M; Vanrenterghem Y; Kuypers D; Evenepoel P; Meijers B
    Clin J Am Soc Nephrol; 2013 Sep; 8(9):1508-14. PubMed ID: 23813557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum indoxyl sulfate concentrations associate with progression of chronic kidney disease in children.
    Holle J; Kirchner M; Okun J; Bayazit AK; Obrycki L; Canpolat N; Bulut IK; Azukaitis K; Duzova A; Ranchin B; Shroff R; Candan C; Oh J; Klaus G; Lugani F; Gimpel C; Büscher R; Yilmaz A; Baskin E; Erdogan H; Zaloszyc A; Özcelik G; Drozdz D; Jankauskiene A; Nobili F; Melk A; Querfeld U; Schaefer F;
    PLoS One; 2020; 15(10):e0240446. PubMed ID: 33108385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Different Types of Oral Adsorbent Therapy in Patients with Chronic Kidney Disease: A Multicenter, Randomized, Phase IV Clinical Trial.
    Kee YK; Han SY; Kang DH; Noh JW; Jeong KH; Kim GH; Kim YW; Kim BS
    Yonsei Med J; 2021 Jan; 62(1):41-49. PubMed ID: 33381933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fecal microbiome and serum concentrations of indoxyl sulfate and p-cresol sulfate in cats with chronic kidney disease.
    Summers SC; Quimby JM; Isaiah A; Suchodolski JS; Lunghofer PJ; Gustafson DL
    J Vet Intern Med; 2019 Mar; 33(2):662-669. PubMed ID: 30561098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease.
    Claro LM; Moreno-Amaral AN; Gadotti AC; Dolenga CJ; Nakao LS; Azevedo MLV; de Noronha L; Olandoski M; de Moraes TP; Stinghen AEM; Pécoits-Filho R
    Toxins (Basel); 2018 Sep; 10(10):. PubMed ID: 30249039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acid retention in chronic kidney disease is inversely related to GFR.
    Goraya N; Simoni J; Sager LN; Pruszynski J; Wesson DE
    Am J Physiol Renal Physiol; 2018 May; 314(5):F985-F991. PubMed ID: 29357423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Levels of Total p-Cresylsulfate Are Associated with Pruritus in Patients with Chronic Kidney Disease.
    Wang CP; Lu YC; Tsai IT; Tang WH; Hsu CC; Hung WC; Yu TH; Chen SC; Chung FM; Lee YJ; Houng JY
    Dermatology; 2016; 232(3):363-70. PubMed ID: 27161100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.